AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Heparin Monotherapy During Primary PCI in STEMI - The Randomized BRIGHT-4 Trial

1,586 views
November 14, 2022
0 Comments
Login to view comments. Click here to Login